SKYE BIOSCIENCE INC: SKYE IS PLANNING TO INITIATE A PHASE 2B CLINICAL TRIAL IN OBESITY FOR NIMACIMAB WITH ENHANZE IN MIDDLE OF 2026

Reuters · 01/05 12:00

Please log in to view news